Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management
For hematocrit and reticulocyte counts, recommendations are to repeat these tests daily from the 5th to 7th days of treatment and then frequently until the hematocrit returns to a normal range
Shahin Asadi, Director, Division of MedicalGenetics and Molecular Research, Iran
It is a peptide, which is a short chain of amino acids
BPC-157, originally isolated from human gastric juice in the 1990s, is a 15-amino acid peptide with remarkable stability and cytoprotective properties
Its 15-amino-acid sequence and stability profile make it one of the most widely referenced compounds in peptide research environments studying recovery and repair mechanisms